However, this study only informs about short-term effects of ß-blockers in patients with mild-to-moderate severe COPD. Long-term effects still need to be investigated.

Current guidelines recommend use of one or more long-acting inhaled bronchodilators for patients with moderate, severe ... subgroups of COPD patients, such as those with more mild disease or ...